Press release
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Expected To Reach $1,431 Million By 2023
For More Info, Get Sample : http://bit.ly/2koFqtk
Increase in geriatric population and changes in lifestyle of people, technological advancements, changes in FDA policy, and increase in prevalence of cardiovascular disorders are expected to drive the market growth. However, availability of alternative therapies and complications associated with PTCA balloon catheters restrain this growth.
The upsurge in demand for minimally invasive surgeries, rise in disposable incomes, and growth prospects in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for market growth during the forecast period.
The report segments the market based on product, delivery platform, compliance, balloon material, and region. Based on product, it is divided into normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. Based on delivery platform it is bifurcated into over-the-wire (OTW) balloon catheter, and rapid exchange (RX)/monorail balloon catheter.
PTCA balloon catheters may either be semi-compliant or non-compliant. Materials such as polyolefin copolymer (POC), polyethylene (PE), and polyethylene terephthalate (PET) are used to manufacture PTCA balloons. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders capitalize on prevailing market opportunities.
• Product and material segmentation analysis helps understand the various types of devices and materials used to manufacture PTCA balloons.
• Comprehensive analysis of all geographical regions is provided, which determines the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global market.
Enquire About Report : http://bit.ly/2BFO6Xp
KEY MARKET SEGMENTS
BY PRODUCT
• Normal balloon catheter
• Drug eluting balloon catheter
• Cutting balloon catheter
• Scoring balloon catheter
BY DELIVERY PLATFORM
• Rapid Exchange (RX) / Monorail balloon catheter
• Over-the-wire (OTW) balloon catheter
BY COMPLIANCE
• Semi-Compliant
• Non-Compliant
BY BALLOON MATERIAL
• Polyolefin copolymer (POC)
• Polyethylene (PE)
• Polyethylene terephthalate (PET)
Also Request For Discount : http://bit.ly/2BbxeXE
BY REGION
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• South Africa
• Saudi Arabia
• Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Abbott Laboratories
• B. Braun Melsungen AG
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• C. R. Bard, Inc.
• Cardinal Health, Inc.
• Medtronic plc
• MicroPort Scientific Corporation
• Terumo Corporation
• THE SPECTRANETICS CORPORATION
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• Lepu Medical Technology (Beijing) Co., Ltd.
• Meril Life Sciences Pvt. Ltd.
• COOK MEDICAL INC.
Table Of Content
• CHAPTER 1 INTRODUCTION
• CHAPTER 2 EXECUTIVE SUMMARY
• CHAPTER 3 MARKET OVERVIEW
• CHAPTER 4 GLOBAL PTCA BALLOON CATHETERS MARKET, BY PRODUCT
• CHAPTER 5 GLOBAL PTCA BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM
• CHAPTER 7 GLOBAL PTCA BALLOON CATHETERS MARKET, BY BALLOON MATERIAL
• CHAPTER 8 PTCA BALLOON CATHETERS MARKET, BY REGION
• CHAPTER 9 COMPANY PROFILES
About Us
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.
Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Expected To Reach $1,431 Million By 2023 here
News-ID: 861004 • Views: …
More Releases from Research Beam Market
Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor…
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period…
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are…
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in…
More Releases for PTCA
Ptca Balloon Catheter Market Prevalent Opportunities up to Forecoming Years
The Ptca Balloon Catheter Market is bound to grow on a gracious note in the next 10 years. The healthcare vertical is shifting to "value" from "production". This shift concerning collaboration (in place of competition) is expected to set new benchmarks in the Ptca Balloon Catheter Market. This fast-moving environment is expected to take the healthcare vertical by storm in the next decade.
Percutaneous transluminal coronary angioplasty (PTCA) refers to a…
PTCA Balloon Catheter Market to Record an Exponential CAGR over 2021
Percutaneous transluminal coronary angioplasty (PTCA) refers to a minimally-invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). PTCA balloon catheters help to allow the blood to flow from the arteries to the heart muscles without the need for open heart surgery.
Coronary heart disease is caused by smoking, high blood pressure, diabetes, and a high level of cholesterol in the blood. Some of the…
Ptca Balloon Catheter Market Forecast By 2021
Percutaneous transluminal coronary angioplasty (PTCA) refers to a minimally-invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). PTCA balloon catheters help to allow the blood to flow from the arteries to the heart muscles without the need for open heart surgery. Coronary heart disease is caused by smoking, high blood pressure, diabetes, and a high level of cholesterol in the blood. Some of the…
PTCA Balloon Catheter Market Estimated to Record Highest CAGR By 2021
Percutaneous transluminal coronary angioplasty (PTCA) refers to a minimally-invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). PTCA balloon catheters help to allow the blood to flow from the arteries to the heart muscles without the need for open heart surgery. Coronary heart disease is caused by smoking, high blood pressure, diabetes, and a high level of cholesterol in the blood. Some of the…
Global and China PTCA Balloon Catheter Research Report to 2021
This report studies PTCA Balloon Catheter in Global and China market, focuses on top manufacturers in global and China market, involving PTCA Balloon Catheter price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of PTCA Balloon Catheter in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011.
Split by product types, with production, revenue,…
PTCA Balloon Catheter Market is Progressing Towards a Strong Growth by 2021
Percutaneous transluminal coronary angioplasty (PTCA) refers to a minimally-invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). PTCA balloon catheters help to allow the blood to flow from the arteries to the heart muscles without the need for open heart surgery. Coronary heart disease is caused by smoking, high blood pressure, diabetes, and a high level of cholesterol in the blood. Some of the…
